Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback